• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical device investing

    LeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%)

    Gabrielle Lakusta
    Feb. 22, 2018 09:34AM PST
    Medical Device Investing

    LeMaitre Vascular (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27% dividend increase to $0.07/share. As quoted in the press release: Record sales of $26.2mm, +12% vs. Q4 2016 Record operating income of $6.3mm vs. $3.9mm, +62% Net income of $4.3mm vs. $2.6mm, +65% Earnings of $0.21 per diluted …

    LeMaitre Vascular (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27% dividend increase to $0.07/share.

    As quoted in the press release:

    • Record sales of $26.2mm, +12% vs. Q4 2016
    • Record operating income of $6.3mm vs. $3.9mm, +62%
    • Net income of $4.3mm vs. $2.6mm, +65%
    • Earnings of $0.21 per diluted share vs. $0.13, +60%
    • Record EBITDA of $7.4mm vs. $4.8mm, +55%

    Click here to read the full press release.

    medical device investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Bristol Myers Squibb Reports First Quarter Financial Results for 2023

    Bristol Myers Squibb Reports First Quarter Financial Results for 2023

    Knight Therapeutics Reports First Quarter 2024 Results

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cleo Diagnostics

    Cleo Diagnostics (COV:AU)
    COV:AU

    Applied UV

    Applied UV (AUVI:NSD)
    AUVI:NSD

    Avricore Health

    Avricore Health (AVCR:CC)
    AVCR:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES